|
1
|
Verma IM, Stevenson JK, Schwarz EM, Van
Antwerp D and Miyamoto S: Rel/NF-kappa B/I kappa B family: Intimate
tales of association and dissociation. Genes Dev. 9:2723–2735.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Baeuerle PA and Baltimore D: NF-kappa B:
Ten years after. Cell. 87:13–20. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Baldwin AS Jr, Azizkhan JC, Jensen DE, Beg
AA and Coodly LR: Induction of NF-kappa B DNA-binding activity
during the G0-to-G1 transition in mouse fibroblasts. Mol Cell Biol.
11:4943–4951. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen FE and Ghosh G: Regulation of DNA
binding by Rel/NF-kappaB transcription factors: Structural views.
Oncogene. 18:6845–6852. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schmitz ML and Baeuerle PA: The p65
subunit is responsible for the strong transcription activating
potential of NF-kappa B. EMBO J. 10:3805–3817. 1991.PubMed/NCBI
|
|
6
|
Karin M, Cao Y, Greten FR and Li ZW:
NF-kappaB in cancer: From innocent bystander to major culprit. Nat
Rev Cancer. 2:301–310. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li Q and Verma IM: NF-kappaB regulation in
the immune system. Nat Rev Immunol. 2:725–734. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hayden MS and Ghosh S: Signaling to
NF-kappaB. Genes Dev. 18:2195–2224. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Duyao MP, Buckler AJ and Sonenshein GE:
Interaction of an NF-kappa B-like factor with a site upstream of
the c-myc promoter. Proc Natl Acad Sci USA. 87:4727–4731. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kessler DJ, Spicer DB, La Rosa FA and
Sonenshein GE: A novel NF-kappa B element within exon 1 of the
murine c-myc gene. Oncogene. 7:2447–2453. 1992.PubMed/NCBI
|
|
11
|
Feng B, Cheng S, Hsia CY, King LB, Monroe
JG and Liou HC: NF-kappaB inducible genes BCL-X and cyclin E
promote immature B-cell proliferation and survival. Cell Immunol.
232:9–20. 2004. View Article : Google Scholar
|
|
12
|
Guttridge DC, Albanese C, Reuther JY,
Pestell RG and Baldwin AS Jr: NF-kappaB controls cell growth and
differentiation through transcriptional regulation of cyclin D1.
Mol Cell Biol. 19:5785–5799. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hinz M, Krappmann D, Eichten A, Heder A,
Scheidereit C and Strauss M: NF-kappaB function in growth control:
Regulation of cyclin D1 expression and G0/G1-to-S-phase transition.
Mol Cell Biol. 19:2690–2698. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou A, Scoggin S, Gaynor RB and Williams
NS: Identification of NF-kappa B-regulated genes induced by
TNFalpha utilizing expression profiling and RNA interference.
Oncogene. 22:2054–2064. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sherr CJ: Mammalian G1 cyclins. Cell.
73:1059–1065. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Beijersbergen RL and Bernards R: Cell
cycle regulation by the retinoblastoma family of growth inhibitory
proteins. Biochim Biophys Acta. 1287:103–120. 1996.PubMed/NCBI
|
|
17
|
Joyce D, Bouzahzah B, Fu M, Albanese C,
D'Amico M, Steer J, Klein JU, Lee RJ, Segall JE, Westwick JK, et
al: Integration of Rac-dependent regulation of cyclin D1
transcription through a nuclear factor-kappaB-dependent pathway. J
Biol Chem. 274:25245–25249. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn
PA, Minna JD and Gallo RC: Detection and isolation of type C
retrovirus particles from fresh and cultured lymphocytes of a
patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA.
77:7415–7419. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yoshida M, Miyoshi I and Hinuma Y:
Isolation and characterization of retrovirus from cell lines of
human adult T-cell leukemia and its implication in the disease.
Proc Natl Acad Sci USA. 79:2031–2035. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kannian P and Green PL: Human T
lymphotropic virus type 1 (HTLV-1): Molecular biology and
oncogenesis. Viruses. 2:2037–2077. 2010. View Article : Google Scholar
|
|
21
|
Satou Y, Yasunaga J, Yoshida M and
Matsuoka M: HTLV-I basic leucine zipper factor gene mRNA supports
proliferation of adult T cell leukemia cells. Proc Natl Acad Sci
USA. 103:720–725. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao T, Yasunaga J, Satou Y, Nakao M,
Takahashi M, Fujii M and Matsuoka M: Human T-cell leukemia virus
type 1 bZIP factor selectively suppresses the classical pathway of
NF-kappaB. Blood. 113:2755–2764. 2009. View Article : Google Scholar
|
|
23
|
Ma Y, Zheng S, Wang Y, Zang W, Li M, Wang
N, Li P, Jin J, Dong Z and Zhao G: The HTLV-1 HBZ protein inhibits
cyclin D1 expression through interacting with the cellular
transcription factor CREB. Mol Biol Rep. 40:5967–5975. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gaudray G, Gachon F, Basbous J,
Biard-Piechaczyk M, Devaux C and Mesnard JM: The complementary
strand of the human T-cell leukemia virus type 1 RNA genome encodes
a bZIP transcription factor that downregulates viral transcription.
J Virol. 76:12813–12822. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hivin P, Frédéric M, Arpin-André C,
Basbous J, Gay B, Thébault S and Mesnard JM: Nuclear localization
of HTLV-I bZIP factor (HBZ) is mediated by three distinct motifs. J
Cell Sci. 118:1355–1362. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao T and Matsuoka M: HBZ and its roles
in HTLV-1 oncogenesis. Front Microbiol. 3:2472012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Guo ZY, Hao XH, Tan FF, Pei X, Shang LM,
Jiang XL and Yang F: The elements of human cyclin D1 promoter and
regulation involved. Clin Epigenetics. 2:63–76. 2011. View Article : Google Scholar
|
|
29
|
Dahlman JM, Wang J, Bakkar N and Guttridge
DC: The RelA/p65 subunit of NF-kappaB specifically regulates cyclin
D1 protein stability: Implications for cell cycle withdrawal and
skeletal myogenesis. J Cell Biochem. 106:42–51. 2009. View Article : Google Scholar
|
|
30
|
Sgambato A, Han EK, Zhang YJ, Moon RC,
Santella RM and Weinstein IB: Deregulated expression of cyclin D1
and other cell cycle-related genes in carcinogen-induced rat
mammary tumors. Carcinogenesis. 16:2193–2198. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee CC, Yamamoto S, Wanibuchi H, Wada S,
Sugimura K, Kishimoto T and Fukushima S: Cyclin D1 overexpression
in rat two-stage bladder carcinogenesis and its relationship with
oncogenes, tumor suppressor genes, and cell proliferation. Cancer
Res. 57:4765–4776. 1997.PubMed/NCBI
|
|
32
|
Sherr CJ: Cancer cell cycles. Science.
274:1672–1677. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Massagué J: G1 cell-cycle control and
cancer. Nature. 432:298–306. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Semczuk A and Jakowicki JA: Alterations of
pRb1-cyclin D1-cdk4/6-p16(INK4A) pathway in endometrial
carcinogenesis. Cancer Lett. 203:1–12. 2004. View Article : Google Scholar
|
|
35
|
Watanabe G, Albanese C, Lee RJ, Reutens A,
Vairo G, Henglein B and Pestell RG: Inhibition of cyclin D1 kinase
activity is associated with E2F-mediated inhibition of cyclin D1
promoter activity through E2F and Sp1. Mol Cell Biol. 18:3212–3222.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lee RJ, Albanese C, Stenger RJ, Watanabe
G, Inghirami G, Haines GK III, Webster M, Muller WJ, Brugge JS,
Davis RJ, et al: pp60(v-src) induction of cyclin D1 requires
collaborative interactions between the extracellular
signal-regulated kinase, p38, and Jun kinase pathways. A role for
cAMP response element-binding protein and activating transcription
factor-2 in pp60(v-src) signaling in breast cancer cells. J Biol
Chem. 274:7341–7350. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ozes ON, Mayo LD, Gustin JA, Pfeffer SR,
Pfeffer LM and Donner DB: NF-kappaB activation by tumour necrosis
factor requires the Akt serine-threonine kinase. Nature. 401:82–85.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pikarsky E, Porat RM, Stein I, Abramovitch
R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E and
Ben-Neriah Y: NF-kappaB functions as a tumour promoter in
inflammation-associated cancer. Nature. 431:461–466. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Karin M: Nuclear factor-kappaB in cancer
development and progression. Nature. 441:431–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Matsuoka M and Jeang KT: Human T-cell
leukaemia virus type 1 (HTLV-1) infectivity and cellular
transformation. Nat Rev Cancer. 7:270–280. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Matsuoka M: Human T-cell leukemia virus
type I (HTLV-I) infection and the onset of adult T-cell leukemia
(ATL). Retrovirology. 2:272005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Mulloy JC, Kislyakova T, Cereseto A,
Casareto L, LoMonico A, Fullen J, Lorenzi MV, Cara A, Nicot C, Giam
C, et al: Human T-cell lymphotropic/leukemia virus type 1 Tax
abrogates p53-induced cell cycle arrest and apoptosis through its
CREB/ATF functional domain. J Virol. 72:8852–8860. 1998.PubMed/NCBI
|
|
43
|
Yoshida M: Multiple viral strategies of
HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol.
19:475–496. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chu ZL, Shin YA, Yang JM, DiDonato JA and
Ballard DW: IKKgamma mediates the interaction of cellular IkappaB
kinases with the tax transforming protein of human T-cell leukemia
virus type 1. J Biol Chem. 274:15297–15300. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Xiao G, Cvijic ME, Fong A, Harhaj EW,
Uhlik MT, Waterfield M and Sun SC: Retroviral oncoprotein Tax
induces processing of NF-kappaB2/p100 in T-cells: Evidence for the
involvement of IKKalpha. EMBO J. 20:6805–6815. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kannagi M, Harada S, Maruyama I, Inoko H,
Igarashi H, Kuwashima G, Sato S, Morita M, Kidokoro M, Sugimoto M,
et al: Predominant recognition of human T-cell leukemia virus type
I (HTLV-I) pX gene products by human CD8+ cytotoxic T
cells directed against HTLV-I-infected cells. Int Immunol.
3:761–767. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Matsumoto J, Ohshima T, Isono O and
Shimotohno K: HTLV-1 HBZ suppresses AP-1 activity by impairing both
the DNA-binding ability and the stability of c-Jun protein.
Oncogene. 24:1001–1010. 2005. View Article : Google Scholar
|
|
48
|
Zhao T, Satou Y, Sugata K, Miyazato P,
Green PL, Imamura T and Matsuoka M: HTLV-1 bZIP factor enhances
TGF-β signaling through p300 coactivator. Blood. 118:1865–1876.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ma G, Yasunaga J, Fan J, Yanagawa S and
Matsuoka M: HTLV-1 bZIP factor dysregulates the Wnt pathways to
support proliferation and migration of adult T-cell leukemia cells.
Oncogene. 32:4222–4230. 2013. View Article : Google Scholar
|
|
50
|
Ressler S, Connor LM and Marriott SJ:
Cellular transformation by human T-cell leukemia virus type I. FEMS
Microbiol Lett. 140:99–109. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kim YM, Geiger TR, Egan DI, Sharma N and
Nyborg JK: The HTLV-1 tax protein cooperates with phosphorylated
CREB, TORC2 and p300 to activate CRE-dependent cyclin D1
transcription. Oncogene. 29:2142–2152. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Harhaj NS, Sun SC and Harhaj EW:
Activation of NF-kappa B by the human T cell leukemia virus type I
Tax oncoprotein is associated with ubiquitin-dependent
relocalization of I kappa B kinase. J Biol Chem. 282:4185–4192.
2007. View Article : Google Scholar
|
